• 1
    Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA, And the Breast Cancer Prognostic Study Associates. Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer. Cancer 1982; 50: 9629.
  • 2
    Bettelheim R, Penman HG, Thornton-Jones H, Neville AM. Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer 1984; 50: 7717.
  • 3
    Miccoli P, Migliori E, Spinelli C, Squartini F, Roncella M, Rossi G, et al. Correlation between 5-year survival of T1-T2-N0 breast cancer and some pathological parameters. Eur J Surg Oncol 1988; 14: 2179.
  • 4
    Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville M. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J clin Pathol 1988; 90: 16.
  • 5
    Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 1989; 7: 123951.
  • 6
    Lee AKC, DeLellis RA, Silverman ML, Heatley GJ, Wolfe HJ. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 1990; 8: 1457651.
  • 7
    Rosen PP, Groshen S, Kinne DW. Prognosis in T2N0M0 stage I breast carcinoma: a 20 year follow-up study. J Clin Oncol 1991; 9: 165061.
  • 8
    Epstein AH, Connolly JL, Gelman R, Schnitt SJ, Silver B, Boyages J, et al. The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy. Int J Radiat Oncol Biol Phys 1989; 17: 75560.
  • 9
    Clayton F. Pathologic correlates of survival in 378 lymph node negative infiltrating ductal breast carcinomas. Cancer 1991; 68: 130917.
  • 10
    Neville AM, Bettelheim R, Gelber RD, Save-Soderbergh J, Davis BW, Reed R, et al. for the International (Ludwig) Breast Cancer Study Group. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. J Clin Oncol 1992; 10: 696705.
  • 11
    Clemente CG, Boracchi P, Andreola S, Del Vecchio M, Veronesi P, Rilke F. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 1992; 69: 13961403.
  • 12
    Fisher ER, Costantino J, Fisher B, Redmond C, And collaborating National Surgical Adjuvant Breast and Bowel Project investigators. Pathologic findings from the National Adjuvant Breast Project (Protocol 4). Cancer 1993; 71: 214150.
  • 13
    Fisher ER, Anderson S, Redmond C, Fisher B for NSABP collaborating investigators. Pathologic findings from the National Surgical Adjuvant Breast Project Protocol B-06. Cancer 1993; 71: 250714.
  • 14
    Genta F, De Sanctis C, Ghiringhello B, Botta G, Gismondi P. Peritumoral blood and lymphatic vessel invasion as a prognostic indicator in stage I breast carcinoma. Int J Oncol 1994; 4: 1637.
  • 15
    Orbo A, Stalsberg H, Kunde D. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics. Cancer 1990; 66: 9727.
  • 16
    Bianco AR, De Placido S, Gallo C, Pagliarulo C, Marinelli A, Petrella G, et al Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study. Lancet 1988: 71: 10959.
  • 17
    De Placido S, Perrone F, Carlomagno C, Morabito A, Pagliarulo C, Lauria R, et al. CMF versus alternating CMF/EV in the adjuvant treatment of operable breast cancer: a single centre randomised clinical trial (Naples GUN-3 study). Br J Cancer 1995; 71: 12837.
  • 18
    Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 45781.
  • 19
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966; 50: 16370.
  • 20
    Cox DR. Regression models and life table. J R Stat Soc 1972 (B) 34: 187220.